Replimune Group Inc Strengthens Leadership Team with Inducement Grant to New CFO
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)WOBURN, Mass., Sept. 19, 2023 – Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of a nove...
Sep 19, 2023
Shares
